1. Home
  2. AZTA vs AMPH Comparison

AZTA vs AMPH Comparison

Compare AZTA & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZTA
  • AMPH
  • Stock Information
  • Founded
  • AZTA 1978
  • AMPH 1996
  • Country
  • AZTA United States
  • AMPH United States
  • Employees
  • AZTA N/A
  • AMPH N/A
  • Industry
  • AZTA Industrial Machinery/Components
  • AMPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • AZTA Technology
  • AMPH Health Care
  • Exchange
  • AZTA Nasdaq
  • AMPH Nasdaq
  • Market Cap
  • AZTA 1.4B
  • AMPH 1.2B
  • IPO Year
  • AZTA 1995
  • AMPH 2014
  • Fundamental
  • Price
  • AZTA $30.83
  • AMPH $25.99
  • Analyst Decision
  • AZTA Buy
  • AMPH Buy
  • Analyst Count
  • AZTA 4
  • AMPH 6
  • Target Price
  • AZTA $42.00
  • AMPH $35.50
  • AVG Volume (30 Days)
  • AZTA 654.4K
  • AMPH 454.6K
  • Earning Date
  • AZTA 11-11-2025
  • AMPH 11-05-2025
  • Dividend Yield
  • AZTA N/A
  • AMPH N/A
  • EPS Growth
  • AZTA N/A
  • AMPH N/A
  • EPS
  • AZTA N/A
  • AMPH 2.68
  • Revenue
  • AZTA $668,821,000.00
  • AMPH $722,679,000.00
  • Revenue This Year
  • AZTA N/A
  • AMPH $1.37
  • Revenue Next Year
  • AZTA $4.18
  • AMPH $6.93
  • P/E Ratio
  • AZTA N/A
  • AMPH $9.68
  • Revenue Growth
  • AZTA 12.46
  • AMPH 1.37
  • 52 Week Low
  • AZTA $23.91
  • AMPH $20.39
  • 52 Week High
  • AZTA $55.64
  • AMPH $53.96
  • Technical
  • Relative Strength Index (RSI)
  • AZTA 52.46
  • AMPH 38.56
  • Support Level
  • AZTA $27.80
  • AMPH $25.96
  • Resistance Level
  • AZTA $33.09
  • AMPH $27.31
  • Average True Range (ATR)
  • AZTA 1.18
  • AMPH 0.73
  • MACD
  • AZTA 0.24
  • AMPH -0.14
  • Stochastic Oscillator
  • AZTA 59.45
  • AMPH 6.14

About AZTA Azenta Inc.

Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: